TVTX · Company research
Travere Therapeutics, Inc. Common Stock (TVTX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 55.98 | $5,607,830,165.84 | 5490095165.84 | — | — | — | 33.0681559925464666 | 228.6856767735095017 | 240.94827557961673971093 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.